Brown, Lisle/Cummings’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2M Buy
23,440
+26
+0.1% +$2.32K 0.5% 46
2025
Q4
$1.85M Buy
23,414
+1,230
+6% +$96.4K 0.46% 51
2025
Q3
$1.77M Sell
22,184
-150
-0.7% -$12.8K 0.46% 52
2025
Q2
$2.03M Hold
22,334
0.54% 48
2025
Q1
$2.09M Buy
22,334
+1,775
+9% +$159K 0.61% 45
2024
Q4
$1.87M Sell
20,559
-350
-2% -$33.4K 0.56% 45
2024
Q3
$2.17M Hold
20,909
0.66% 38
2024
Q2
$2.03M Buy
20,909
+1,750
+9% +$161K 0.66% 37
2024
Q1
$1.73M Sell
19,159
-50
-0.3% -$4.24K 0.59% 45
2023
Q4
$1.53M Buy
19,209
+6,337
+49% +$476K 0.57% 44
2023
Q3
$915K Buy
12,872
+2,866
+29% +$214K 0.41% 58
2023
Q2
$771K Buy
10,006
+8,018
+403% +$621K 0.34% 64
2023
Q1
$149K Hold
1,988
0.08% 189
2022
Q4
$157K Buy
1,988
+75
+4% +$5.62K 0.08% 179
2022
Q3
$134K Hold
1,913
0.08% 181
2022
Q2
$153K Hold
1,913
0.08% 176
2022
Q1
$145K Hold
1,913
0.07% 194
2021
Q4
$163K Buy
+1,913
New +$149K 0.08% 176

Other funds holding CL

Brown, Lisle/Cummings's CL Position: Q1 2026 in Review

Brown, Lisle/Cummings increased its Colgate-Palmolive (CL) stake by 0.11% in Q1 2026, buying an estimated $2.32K and bringing the position to 23,440 shares worth $2M. The position accounts for 0.5% of the portfolio, ranked #46.

Brown, Lisle/Cummings first reported a position in CL in Q4 2021 and has held it in 18 quarters since. The position peaked at $2.17M in Q3 2024. 1,945 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • Brown, Lisle/Cummings held 23,440 shares of Colgate-Palmolive worth $2M as of Q1 2026.
  • Brown, Lisle/Cummings bought 26 Colgate-Palmolive shares in Q1 2026, an estimated $2.32K.
  • Colgate-Palmolive made up 0.5% of Brown, Lisle/Cummings's portfolio in Q1 2026, its #46 holding.
  • Brown, Lisle/Cummings first reported a position in Colgate-Palmolive in Q4 2021 and has held it in 18 quarters since.
  • Brown, Lisle/Cummings's Colgate-Palmolive position peaked at $2.17M in Q3 2024.
  • 1,945 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Brown, Lisle/Cummings's 13F filing for Q1 2026, filed 20 Apr 2026.